|
Market Closed -
NYSE
21:01:58 11/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 470.90 USD | -0.97% |
|
+0.71% | +23.98% |
| 11-10 | Waters Says US FDA Clearance Obtained for Leukemia, Lymphoma Clinical Tests | MT |
| 11-10 | Waters Corporation Announces FDA 510(k) Clearance For BD OneFlow LST Test And BD OneFlow B-CLPD T1 Test | CI |
| Market Cap | 46.28B 41.71B 38.54B 34.84B 65.91B 4,341B 67.54B 462B 184B 2,325B 174B 170B 7,398B | P/E 2026 * |
105x | P/E 2027 * | 41.9x |
|---|---|---|---|---|---|
| Enterprise Value | 50.38B 45.41B 41.95B 37.92B 71.75B 4,725B 73.52B 503B 200B 2,531B 189B 185B 8,053B | EV / Sales 2026 * |
7.76x | EV / Sales 2027 * | 6.86x |
| Free-Float |
48.61% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| WAT | Delayed | |
| WAT | Real-time | ||
| WAZ | Real-time | ||
| WAZ | Delayed | ||
| 0LTI | Delayed | ||
| WAZ | End-of-day quote | ||
| WAZ | Delayed | ||
| WAZ | Real-time | ||
| 1WAT | End-of-day quote | ||
| WAZ | Delayed | ||
| WTRS | End-of-day quote |
Last Transcript: Waters Corporation
| 1 day | -0.97% | ||
| 1 week | +0.71% | ||
| Current month | +1.77% | ||
| 1 month | +8.56% | ||
| 3 months | +13.47% | ||
| 6 months | +35.29% | ||
| Current year | +23.98% |
| 1 week | 450.61 | 483.33 | |
| 1 month | 422.82 | 483.33 | |
| Current year | 282.77 | 483.33 | |
| 1 year | 282.77 | 483.33 | |
| 3 years | 249.34 | 483.33 | |
| 5 years | 231.9 | 483.33 | |
| 10 years | 133.35 | 483.33 |
| Manager | Title | Age | Since |
|---|---|---|---|
Udit Batra
CEO | Chief Executive Officer | 55 | 31/08/2020 |
Amol Chaubal
DFI | Director of Finance/CFO | 50 | 11/05/2021 |
Brook Colangelo
CTO | Chief Tech/Sci/R&D Officer | 48 | 28/02/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | 30/04/2006 | |
Flemming Ørnskov
CHM | Chairman | 68 | 31/12/2019 |
Linda Baddour
BRD | Director/Board Member | 68 | 31/08/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/09/26 | Free | Director | 57 | 0.0001% | ||
| 30/09/26 | Free | Director | 57 | 0.0001% | ||
| 06/08/26 | Exercice | Director | 10,878 | 0.0111% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.97% | +0.71% | +21.95% | +84.00% | 46.72B | ||
| -0.07% | +1.64% | +22.37% | +60.05% | 266B | ||
| -0.34% | +0.16% | +9.05% | +19.45% | 166B | ||
| -0.11% | -6.76% | -21.43% | +62.00% | 156B | ||
| +0.96% | -1.51% | -55.97% | -12.47% | 64.79B | ||
| +1.73% | +6.48% | +24.25% | +64.79% | 59.81B | ||
| +1.35% | -2.97% | -2.05% | -8.59% | 53.3B | ||
| -0.52% | -0.12% | +18.42% | +63.13% | 50.15B | ||
| -0.26% | -1.89% | +1.90% | +84.62% | 49.47B | ||
| -1.26% | -3.74% | +12.52% | +18.81% | 37.82B | ||
| Average | +0.04% | -0.52% | +3.10% | +43.58% | 95B | |
| Weighted average by Cap. | -0.00% | -0.53% | +4.57% | +45.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.49B 5.85B 5.4B 4.89B 9.24B 609B 9.47B 64.77B 25.82B 326B 24.36B 23.84B 1,038B | 7.17B 6.46B 5.97B 5.39B 10.21B 672B 10.46B 71.51B 28.5B 360B 26.89B 26.32B 1,145B |
| Net income | 445M 401M 370M 335M 633M 41.71B 649M 4.44B 1.77B 22.34B 1.67B 1.63B 71.09B | 1.05B 948M 876M 792M 1.5B 98.64B 1.53B 10.5B 4.18B 52.83B 3.95B 3.86B 168B |
| Net Debt | 4.1B 3.69B 3.41B 3.08B 5.83B 384B 5.98B 40.87B 16.29B 206B 15.37B 15.04B 655B | 2.88B 2.59B 2.4B 2.17B 4.1B 270B 4.2B 28.72B 11.45B 145B 10.8B 10.57B 460B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/11/26 | US$470.90 | -0.97% | 651,925 |
| 10/11/26 | US$475.52 | -0.25% | 889,329 |
| 09/11/26 | US$476.70 | +4.17% | 1,137,441 |
| 06/11/26 | US$457.60 | +1.00% | 695,778 |
| 05/11/26 | US$453.08 | -3.11% | 1,149,804 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- WAT Stock
Select your edition
All financial news and data tailored to specific country editions
















